Cerebral angiogenesis after subarachnoid hemorrhage (SAH) and endothelin receptor blockage with BQ-123 antagonist in rats

被引:0
|
作者
Josko, J
Hendryk, S
Jedrzejowska-Szypulka, H
Slowinski, J
Gwózdz, B
Lange, D
Snietura, M
Zwirska-Korczala, K
Jochem, J
机构
[1] Silesian Univ, Sch Med, Dept Physiol, PL-41808 Zabrze, Poland
[2] Silesian Univ, Sch Med, Dept Neurosurg & Neurotraumatol, Bytom, Poland
[3] Inst Oncol, Dept Tumor Pathol, Gliwice, Poland
来源
关键词
subarachnoid hemorrhage; endothelin-1; antagonist ETA receptors - BQ-123; angiogenesis;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The aim of the study was to determine the effect of chronic vasospasm after SAH on angiogenesis and the effect of endothelin-1 the main causative factor in vasospasm, on this process. Male Wistar rats, 220-250 g, were examined. Seven days after cannulation of the cisterna magna (CM), a 100 mul dose of non-heparinized blood was administered to induce SAH. Sham SAH (aSAH) was induced by intracisternal injection of 100 mul of artificial cerebrospinal fluid. Endothelin receptor antagonist BQ-123 in a dose of 40 nmol in 50 mul of cerebrospinal fluid was given three times: 20 min. before SAH and aSAH, 60 min and 23 hours after SAH and aSAH. The same pattern of BQ-123 administration was used in the nonSAH group. The brains were removed 48 hours later for histological evaluation. Vascular surface density was measured in cerebral hemisphere sections (at the level of the dorsal part of the hippocampus) and brain stem sections (1/2 of the pens). An increase in angiogenesis was observed after SAH, compared to control values. The administration of BQ-123. a specific endothelin receptor blocker inhibits angiogenesis in cerebral hemispheres after SAH.
引用
收藏
页码:237 / 248
页数:12
相关论文
共 50 条
  • [21] Effect of BQ-123 and tissue plasminogen activator on vasospasm after subarachnoid hemorrhage in monkeys
    Kim, CJ
    Bassiouny, M
    Macdonald, RL
    Weir, B
    Johns, LM
    STROKE, 1996, 27 (09) : 1629 - 1633
  • [22] Effects of Endothelin-A Receptor Antagonist BQ-123 on Plasma Leptin Levels in Streptozotocin-induced Diabetic Rats
    Ozturk, A.
    Erdogan, H.
    Ekici, F.
    Aydin, D.
    Sogut, E.
    WEST INDIAN MEDICAL JOURNAL, 2023, 70 (01): : 61 - 68
  • [23] EFFECT OF ENDOTHELIN ANTAGONIST BQ-123 ON THE DEVELOPMENT OF SEVERE PULMONARY-HYPERTENSION IN CMS IN RATS
    DU, HK
    LEITER, JC
    OU, LC
    FASEB JOURNAL, 1995, 9 (04): : A649 - A649
  • [24] EFFECTS OF BQ-123, A NOVEL ENDOTHELIN RECEPTOR ANTAGONIST, ON CONDUIT PULMONARY BLOOD-VESSELS
    CAI, B
    SUMMER, W
    HYMAN, A
    LIPPTON, H
    CLINICAL RESEARCH, 1992, 40 (04): : A796 - A796
  • [25] Effects of endothelin(A) receptor (ET(A)) antagonist (BQ-123) on the acute myocardial ischaemia with reperfusion in dogs
    Alberola, A
    Revert, F
    Moya, A
    Garcia, J
    Beltran, J
    Sancho, S
    Such, L
    JOURNAL OF PHYSIOLOGY-LONDON, 1996, 493P : S77 - S77
  • [26] ENDOTHELIN-A RECEPTOR ANTAGONIST (BQ-123) PREVENTS ACUTE-HYPOXIA INDUCED PULMONARY-HYPERTENSION IN RATS
    CHEN, SJ
    MENG, Q
    ELTON, T
    YANO, M
    OPARIL, S
    CHEN, YF
    FASEB JOURNAL, 1993, 7 (04): : A649 - A649
  • [27] ENDOTHELIN ANTAGONIST BQ-123 AMELIORATES HYPOXIA-INDUCED PULMONARY-HYPERTENSION IN RATS
    TJENALOOI, S
    EKMAN, R
    CARY, J
    KEITH, I
    FASEB JOURNAL, 1993, 7 (04): : A544 - A544
  • [28] THE ENDOTHELIN RECEPTOR ANTAGONIST, BQ-123, INHIBITS ANGIOTENSIN II-INDUCED CONTRACTIONS IN RABBIT AORTA
    WEBB, ML
    DICKINSON, KEJ
    DELANEY, CL
    LIU, ECK
    SERAFINO, R
    COHEN, RB
    MONSHIZADEGAN, H
    MORELAND, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 185 (03) : 887 - 892
  • [29] Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects
    Wimalasundera, RC
    Thom, SAM
    Regan, L
    Hughes, AD
    CLINICAL SCIENCE, 2002, 102 (06) : 661 - 666
  • [30] ANTIHYPOTENSIVE EFFECTS OF BQ-123, A SELECTIVE ENDOTHELIN ET(A) RECEPTOR ANTAGONIST, IN SPONTANEOUSLY HYPERTENSIVE RATS TREATED WITH DOCA-SALT
    OKADA, M
    FUKURODA, T
    SHIMAMOTO, K
    TAKAHASHI, R
    IKEMOTO, F
    YANO, M
    NISHIKIBE, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 259 (03) : 339 - 342